Payden & Rygel Investment Group’s CME Group CME Stock Holding History
Bought
Maintained
Sold
Other funds holding CME
Payden & Rygel Investment Group's CME Position: Q2 2024 in Review
Payden & Rygel Investment Group increased its CME Group (CME) stake by 1,142% in Q2 2024, buying an estimated $6.14M and bringing the position to 32,300 shares worth $6.35M. The position accounts for 0.51% of the portfolio, ranked #68.
Payden & Rygel Investment Group first reported a position in CME in Q3 2023 and has held it in 3 quarters since. 1,377 funds tracked by Wall St. Rank hold CME as of Q2 2024.
- Payden & Rygel Investment Group held 32,300 shares of CME Group worth $6.35M as of Q2 2024.
- Payden & Rygel Investment Group bought 29,700 CME Group shares in Q2 2024, an estimated $6.14M.
- CME Group made up 0.51% of Payden & Rygel Investment Group's portfolio in Q2 2024, its #68 holding.
- Payden & Rygel Investment Group first reported a position in CME Group in Q3 2023 and has held it in 3 quarters since.
- 1,377 funds tracked by Wall St. Rank held CME Group as of Q2 2024.
Based on Payden & Rygel Investment Group's 13F filing for Q2 2024, filed 12 Aug 2024.